SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending as a government shutdown looms, sparking debate about potential market impact. The community is discussing whether history will repeat itself with markets brushing off the event, or if current high valuations and economic fragility will lead to a downturn. Some traders are anticipating volatility and preparing for potential opportunities.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as the U.S. government shutdown looms, sparking debate about its potential market impact. While some anticipate a pullback, others believe a shutdown is already priced in or could even be bullish, leading to volatility. Community members are actively discussing potential trading strategies amidst the uncertainty.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community rallies around the crypto, emphasizing its ties to culture, freedom, and digital growth. The conversation highlights Weedcoin as more than just a token, but a movement and a symbol of innovation. Community members are also celebrating its trending status alongside other cryptos like $UPDOG.X.

Lithium Americas Corp. engages in the development of the Thacker Pass project. It is focused on advancing Thacker Pass to production it is located in northern Nevada. The company was founded on January 23, 2023 and is headquartered in Vancouver, Canada.

Lithium Americas Corp (NewCo)

Lithium Americas Corp

Lithium Americas ($LAC) is trending following confirmation that the U.S. government will take a stake in the company and its Thacker Pass lithium project. This move is viewed by the community as a major win, solidifying the project's importance for domestic lithium supply. Some traders are drawing parallels to previous government-backed runs in other sectors, anticipating a significant price increase.

BYTE is a novel meme token that creatively intertwines the worlds of cryptocurrency and popular culture. Inspired by Grok's answer to "What would you name your dog?", Grok answered, 'Byte.' When Grok was asked who created Byte, it says he was created by the xAI team lead by Elon Musk as a gift to Grok AI to keep him company in the metaverse. BYTE serves as a playful reference to the unit of digital information, as well as a nod to the AI's technological nature. Distinctively, Byte acts as a gateway towards Ai adoption and stands out in the crypto space due to its zero-tax policy, a feature that is increasingly appealing to many investors. Additionally, it upholds the principles of transparency and investor trust by having its liquidity permanently burned and the contract ownership renounced. This ensures that Byte remains a community-driven project, with its fate firmly in the hands of its holders. The combination of a playful theme, generative AI, and a nod to a tech icon makes Byte an intriguing addition to the meme token ecosystem, especially AI related meme coins.  Through pioneering AI this story has grown more and more robust and continues to evolve, Byte pledges its dedication to community efforts and and has consistently appeared in the Top 10 of LunarCrush’s social engagement leaderboards on multiple occasions.

BYTE

$BYTE.X is gaining attention as the 'pup' of xAI, with community members suggesting a connection to Elon Musk and a potential role in future AI developments; some users claim that positive sentiment from the community may be fueling Grok, while others point to its strong community as a reason to invest. Amidst the hype, some caution is being urged to DYOR, as a fake Solana token of the same name circulates.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MLTX is trending as the community discusses a potential rebound after a significant drop, speculating that it was an overreaction to trial data. Chatter revolves around the possibility of a short squeeze and a return to previous price levels, with some mentioning a previous buyout offer. Investors are weighing the company's cash position and pipeline, with many expressing a bullish outlook.

its a Meme token and beta to Troll The "Lenny face  is a text-based emoticon, ( ͡° ͜ʖ ͡°), used to convey a range of emotions, particularly mischief, sexual innuendo, or a hidden meaning. It's often employed in online discussions to add a playful or suggestive tone to a message, or sometimes even to spam threads, according to Wikipedia. The symbol is visually interpreted as a face with two eyes (small circles), a nose (squiggly line), and a mouth (curved line).

Lenny

$LENNY.X is trending as the community rallies around the 'Lenny face' meme, calling it the 'OG internet meme' and a 'digital fossil fuel'. Community members are expressing strong conviction, emphasizing community-building, dismissing concerns around dips, and touting the potential for significant gains, referring to themselves as the 'Lenny Army'.

Bakkt Holdings, Inc. engages in the intersection of cryptoassets, loyalty and rewards, and payments. It also provides a platform to expand payment offerings, create new revenue streams, and increase customer loyalty. The company was founded in 2018 and is headquartered in Alpharetta, GA.

Bakkt Holdings Inc - Ordinary Shares - Class A

Bakkt Holdings Inc

Bakkt is trending due to renewed interest after a new board appointment, sparking discussions about the company's potential growth strategy within the digital asset space. Bullish sentiment is building around the possibility of a short squeeze and the company's strengthened financial position. The community is actively speculating about the impact of new leadership and potential partnerships.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amid discussions about a potential government shutdown and its implications, with community members debating the political blame and potential economic consequences. Some investors are expressing concerns about the stock's performance, while others remain supportive of the company and its leadership. Broader political issues, such as military involvement in domestic affairs and healthcare funding, are also being actively discussed in relation to the stock.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending amid news of a potential drug-pricing deal with the Trump administration and a $70 billion investment in R&D and U.S. manufacturing. Community discussion revolves around the deal's impact on drug prices, PFE's low valuation, the potential political ramifications, and the company's long-term growth prospects in a competitive pharmaceutical landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Clearmind Medicine Files International Patent For Ibogaine Combination Therapy

Clearmind Medicine filed an international patent for a treatment that aims to enhance addiction treatment safety and efficacy.
read more...

Could Psychedelics End Binge Drinking? A Breakthrough Patent Says Yes

Clearmind Medicine secures a U.S. patent for its MEAI-based binge behavior treatment, marking a significant advancement in addressing Alcohol Use Disorder.
read more...

Why Psychedelic-Pharma Clearmind Medicine Stock Is Moving Higher

Clearmind Medicine shares are trading higher Friday after the company announced advancement in its proprietary MEAI-based binge behavior regulator program through the granting of patent approval in...

What's Going On With Clearmind Medicine Stock Tuesday?

Clearmind said its alcohol substitute was granted patents in the U.S., India and Europe. The company also highlighted that the no/low alcohol category is forecasted to grow at a volume CAGR of more...

Why Clearmind Medicine Stock Is Moving Higher

Clearmind Medicine shares are up Tuesday after the company announced it signed an exclusive patent licensing agreement with Yissum Research Development.
read more...

Short Interest in Clearmind Medicine Inc. (NASDAQ:CMND) Declines By 59.8%

Clearmind Medicine Inc. (NASDAQ:CMND  Get Free Report) saw a significant decline in short interest in March. As of March 15th, there was short interest totalling 92,700 shares, a decline of...

Clearmind Medicine Announces International Patent Application for Preventing and Treating Depression

Vancouver, Canada, March 27, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY) ( Clearmind or the company ), a biotech company focused on discovery and development of...

SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression

TEL AVIV, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...

Clearmind Medicine granted divisional patent approval in China

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China

A Novel Approach to Combatting Binge Behaviors with Groundbreaking Psychedelic Therapy Tel Aviv, Israel / Vancouver, Canada, March 19, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq...

Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize it as regulated medicines, foods, or supplements. The company was founded on July 18, 2017 and is headquartered in Vancouver, Canada.

Clearmind Medicine Inc

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

Current Price	$1.03
Prev Close	$1.00
Open	$1.01
Dividend Yield	0.00%
50-Day Moving Average	$1.03
Beta	0.42
Avg. Volume	59,717.76
PE Ratio	-1.18

52-Week High	$2.18
52-Week Low	$0.80
Market Capitalization	$3.17M
EPS (Annual)	-$1.70
Price to Book	5.05
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

CMND
Clearmind Medicine Inc

Feed

News

Sentiment

Fundamentals

Info

Latest CMND News

CMND Clearmind Medicine Inc